U.S. Capital Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-5,876
| Closed | -$53.6K | – | 1434 |
|
2022
Q4 | $53.6K | Buy |
+5,876
| New | +$53.6K | ﹤0.01% | 865 |
|
2022
Q3 | – | Sell |
-10,226
| Closed | -$77K | – | 680 |
|
2022
Q2 | $77K | Hold |
10,226
| – | – | ﹤0.01% | 648 |
|
2022
Q1 | $96K | Sell |
10,226
-2,700
| -21% | -$25.3K | ﹤0.01% | 689 |
|
2021
Q4 | $104K | Sell |
12,926
-116,736
| -90% | -$939K | ﹤0.01% | 696 |
|
2021
Q3 | $1.26M | Buy |
+129,662
| New | +$1.26M | 0.05% | 343 |
|